GT Biopharma, Inc. (GTBP)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-490.0%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | $0 | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — | $0 | $0 |
| Gross Profit | — | — | — | — | — | — | — | — | $0 | $0 |
| Operating Income | -$12.42M | -$14.36M | -$13.58M | -$21.26M | -$57.52M | -$6.76M | $16.06M | -$250.07M | -$135.57M | -$9.37M |
| Net Income | -$28.35M | -$13.16M | -$7.60M | -$20.88M | -$58.01M | -$28.30M | -$38.65M | -$259.19M | -$144.17M | $9.77M |
| EPS (Diluted) | $-6.68 | $-6.94 | $-5.64 | $-19.66 | $-2.06 | — | — | $-5.16 | $-8.60 | $119.91 |
| Total Assets | $8.11M | $4.23M | $14.11M | $16.74M | $32.17M | $5.66M | $396.0K | $25.40M | $254.37M | $25.0K |
| Total Liabilities | $1.32M | — | $6.63M | $5.00M | $10.26M | — | $19.71M | $14.03M | $2.68M | $18.95M |
| Shareholders' Equity | $5.79M | -$1.67M | $7.48M | $11.73M | $21.91M | -$29.43M | -$19.31M | $11.37M | $251.69M | -$18.92M |
| Cash & Equivalents | $6.81M | $3.95M | $1.08M | $5.67M | $8.97M | $5.30M | $28.0K | $60.0K | $576.0K | $19.0K |
| Operating Cash Flow | -$12.91M | -$12.90M | -$8.85M | -$15.22M | -$15.61M | -$7.26M | -$3.66M | -$10.68M | -$5.43M | -$1.93M |
| Capital Expenditures | — | — | — | — | — | — | $0 | $36.0K | $4.0K | $0 |
| Shares Outstanding | 25.53M | 2.23M | 1.38M | 1.09M | 32.06M | 5.22M | 4.10M | 50.65M | 50.12M | 104.2K |